Literature DB >> 20226221

Orthologs of magainin, PGLa, procaerulein-derived, and proxenopsin-derived peptides from skin secretions of the octoploid frog Xenopus amieti (Pipidae).

J Michael Conlon1, Nadia Al-Ghaferi, Eman Ahmed, Mohammed A Meetani, Jérôme Leprince, Per F Nielsen.   

Abstract

The Volcano clawed frog Xenopus amieti Kobel, du Pasquier, Fischberg, and Gloor, 1980, with a chromosome number of 2n=72, is believed to have undergone two rounds of genome duplication since evolving from a diploid ancestor. Nine peptides with differential antimicrobial activity against Escherichia coli and Staphylococcus aureus were isolated from norepinephrine-stimulated skin secretions of X. amieti that showed structural similarity to peptides previously isolated from the tetraploid frog X. laevis (2n=36) and the diploid frog Silurana (formerly Xenopus) tropicalis (2n=20). Two peptides (magainin-AM1 and -AM2) are othologous to the magainins, two peptides (PGLa-AM1 and -AM2) orthologous to peptide glycine-leucine-amide, four peptides (CPF-AM1, -AM2, -AM3, -AM4) orthologous to caerulein-precursor fragments, and one peptide (XPF-AM1) structurally similar to xenopsin-precursor fragments were characterized. CFP-AM1 (GLGSVLGKALKIGANLL.NH(2)) was the most potent peptide present in the secretions and magainin-AM2 (GVSKILHSAGKFGKAFLGEIMKS) was the most abundant. The data indicate that nonfunctionalization has been the most common fate of duplicated antimicrobial peptide genes following the polyploidization events in the X. amieti lineage. However, the very low antimicrobial activity of the magainin-AM1 and PGLa-AM2 paralogs suggests the possibility that certain peptides may have evolved toward a new, as yet undetermined, function (neofunctionalization). Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20226221     DOI: 10.1016/j.peptides.2010.03.002

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  8 in total

Review 1.  Structural diversity and species distribution of host-defense peptides in frog skin secretions.

Authors:  J Michael Conlon
Journal:  Cell Mol Life Sci       Date:  2011-05-11       Impact factor: 9.261

Review 2.  Antimicrobial Peptide Analogs From Scorpions: Modifications and Structure-Activity.

Authors:  Bruno Amorim-Carmo; Adriana M S Parente; Eden S Souza; Arnóbio A Silva-Junior; Renata M Araújo; Matheus F Fernandes-Pedrosa
Journal:  Front Mol Biosci       Date:  2022-05-26

Review 3.  The Potential of Frog Skin-Derived Peptides for Development into Therapeutically-Valuable Immunomodulatory Agents.

Authors:  Jelena M Pantic; Ivan P Jovanovic; Gordana D Radosavljevic; Nebojsa N Arsenijevic; J Michael Conlon; Miodrag L Lukic
Journal:  Molecules       Date:  2017-12-13       Impact factor: 4.411

4.  Selection of antimicrobial frog peptides and temporin-1DRa analogues for treatment of bacterial infections based on their cytotoxicity and differential activity against pathogens.

Authors:  Rogier A Gaiser; Jaione Ayerra Mangado; Milena Mechkarska; Wendy E Kaman; Peter van Baarlen; J Michael Conlon; Jerry M Wells
Journal:  Chem Biol Drug Des       Date:  2020-09-19       Impact factor: 2.817

5.  Origin and functional diversification of an amphibian defense peptide arsenal.

Authors:  Kim Roelants; Bryan G Fry; Lumeng Ye; Benoit Stijlemans; Lea Brys; Philippe Kok; Elke Clynen; Liliane Schoofs; Pierre Cornelis; Franky Bossuyt
Journal:  PLoS Genet       Date:  2013-08-01       Impact factor: 5.917

6.  Host-defense peptides with therapeutic potential from skin secretions of frogs from the family pipidae.

Authors:  J Michael Conlon; Milena Mechkarska
Journal:  Pharmaceuticals (Basel)       Date:  2014-01-15

7.  Low structural variation in the host-defense peptide repertoire of the dwarf clawed frog Hymenochirus boettgeri (Pipidae).

Authors:  Severine Matthijs; Lumeng Ye; Benoit Stijlemans; Pierre Cornelis; Franky Bossuyt; Kim Roelants
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

Review 8.  Drug Delivery Strategies for Enhancing the Therapeutic Efficacy of Toxin-Derived Anti-Diabetic Peptides.

Authors:  Reeju Amatya; Taehoon Park; Seungmi Hwang; JaeWook Yang; Yoonjin Lee; Heesun Cheong; Cheol Moon; Hyun Duck Kwak; Kyoung Ah Min; Meong Cheol Shin
Journal:  Toxins (Basel)       Date:  2020-05-10       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.